EUVIMEDEUVIMED entdecken
Crossref

Discovery and in vitro Evaluation of Novel Serotonin 5‐HT 2A Receptor Ligands Identified Through Virtual Screening

Agata Zięba iD, Damian Bartuzi iD, Piotr Stępnicki iD, Dariusz Matosiuk iD, Tomasz M Wróbel iD, Tuomo Laitinen iD, Marián Castro iD, Agnieszka A Kaczor iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Agata Zięba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modelling Lab, Faculty of Pharmacy, Medical University of …. Hauptthemen laut MEDLINE: Receptor, Serotonin, 5-HT2A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Medical University of Lublin, Poland, Young Researchers to A.Z, Spanish Ministry of Economy and Competitiveness (MINECO).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 5‐HT 2A receptor is a molecular target of high pharmacological importance. Ligands of this protein, particularly atypical antipsychotics, are useful in the treatment of numerous mental disorders, including schizophrenia and major depressive disorder. Structure‐based virtual screening using a 5‐HT 2A receptor complex was performed to identify novel ligands for the 5‐HT 2A receptor, serving as potential antidepressants. From the Enamine screening library, containing over 4 million compounds, 48 molecules were selected for subsequent experimental validation. These compounds were tested against the 5‐HT 2A receptor in radioligand binding assays. From the tested batch, six molecules were identified as ligands of the main molecular target and were forwarded to a more detailed in vitro profiling. This included radioligand binding assays at 5‐HT 1A , 5‐HT 7 , and D 2 receptors and functional studies at 5‐HT 2A receptors. These compounds were confirmed to show a binding affinity for at least one of the targets tested in vitro . The success rate for the inactive template‐based screening reached 17 %, while it was 9 % for the active template‐based screening. Similarity and fragment analysis indicated the structural novelty of the identified compounds. Pharmacokinetics for these molecules was determined using in silico approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Serotonin, 5-HT2ALigandsHumansStructure-Activity RelationshipDrug Evaluation, PreclinicalDrug DiscoveryMolecular StructureMolecular Docking Simulation

Stichwörter der Autor:innen

antidepressantsantipsychoticsdrug discoveryserotonin receptorvirtual screening

Substanzen

Receptor, Serotonin, 5-HT2ALigands

Autor:innen und Institutionen

  • Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modelling Lab, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki St., 20059, Lublin, Poland.
  • Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, 75124, Uppsala, Sweden.
  • School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, 70211, Kuopio, Finland.
  • Department of Pharmacology, Universidade de Santiago de Compostela, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Avda. de Barcelona, 15782, Santiago de Compostela, Spain.
  • Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Travesía da Choupana s/n, E-15706, Santiago de Compostela, Spain.

ORCID-Profile: Agata Zięba, Damian Bartuzi, Piotr Stępnicki, Dariusz Matosiuk, Tomasz M Wróbel, Tuomo Laitinen, Marián Castro, Agnieszka A Kaczor

Förderung

  • Medical University of Lublin, Poland
  • Young Researchers to A.Z
  • Spanish Ministry of Economy and Competitiveness (MINECO)
  • Biocenter Finland/DDCB

Zitieren

APA

Zięba, A., Bartuzi, D., Stępnicki, P., Matosiuk, D., Wróbel, T. M., Laitinen, T., Castro, M., & Kaczor, A. A. (2024). Discovery and in vitro Evaluation of Novel Serotonin 5‐HT 2A Receptor Ligands Identified Through Virtual Screening. ChemMedChem. https://doi.org/10.1002/cmdc.202400080

Vancouver

Zięba A, Bartuzi D, Stępnicki P, Matosiuk D, Wróbel TM, Laitinen T, et al. Discovery and in vitro Evaluation of Novel Serotonin 5‐HT 2A Receptor Ligands Identified Through Virtual Screening. ChemMedChem. 2024. doi:10.1002/cmdc.202400080

BibTeX
@article{Ziba2024,
  author = {Zięba, Agata and Bartuzi, Damian and Stępnicki, Piotr and Matosiuk, Dariusz and Wróbel, Tomasz M and Laitinen, Tuomo and Castro, Marián and Kaczor, Agnieszka A},
  title = {Discovery and in vitro Evaluation of Novel Serotonin 5‐HT 2A Receptor Ligands Identified Through Virtual Screening},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400080}
}
Kostenlos starten →